Hideto Ansai

1PUBLICATIONS
1CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jul 13, 2022
Plasma exchange and infliximab as a third-line therapy for refractory infantile Kawasaki disease.

Hideto Ansai, Hiroshi Masuda, Hiro Nakao

Pageof 1

Frequent Collaborators

1 joint publications

Hiro Nakao